Symphogen's Series D Round

Symphogen raised a round of funding on January 16, 2006.

Symphogen is developing next-generation antibody therapeutics for the treatment of cancer and is dedicated to bringing truly innovative oncology products to the market. The company has advanced the fr…

Articles about Symphogen's Series D Round: